Xiaolu Gao

Xiaolu Gao

Auto-generated profile, based on publicly available information

Xiaolu Gao

The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in Chinese Journal of Population, Resources and Environment
Verified
Journal Article
Closed access
DJDai Junliang
Dai Junliang
XGXiaolu Gao
Xiaolu Gao
DSDu Shoushuai
Du Shoushuai
Urban expansion brought by the rapid progress of urbanization has caused many problems in China. It is a significant issue to evaluate the extent of urban expansion and to make appropriate controls over the sprawl of urban areas. With a comparative study of international experiences, this article analyzed the mechanism and consequences of urban expansion, reviewed the typical planning and financial policies adopted by other countries for controlling urban sprawl, and discussed the suitable densities of urban areas. The analysis results suggested that Chinese cities have no better choice but compact urban forms. To achieve the goal of compact development, intensive use of public transportation and high proportion of collective houses should be encouraged, and 60–100 m2 per capita is recommended as the reasonable range of urban density in large cities.

15 January 2014 in International Review for Spatial Planning and Sustainable Development
Verified
Journal Article
Open access
XGXiaolu Gao
Xiaolu Gao
HYHaihong Yuan
Haihong Yuan
WQWei Qi
Wei Qi
SLShenghe Liu
Shenghe Liu

1 May 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
PGPengfei Gao
Pengfei Gao
XGXiaolu Gao
Xiaolu Gao
LLLong Lin
Long Lin
MZMing Zhang
Ming Zhang
DLDongqiang Luo
Dongqiang Luo
RYRuisi Yang
Ruisi Yang
Background: Psoriasis is an immune-mediated skin disease where Th17 cell differentiation and IL-17 secretion play critical roles. This study investigates key exosomal ncRNAs regulating the Th17/IL-17 axis in psoriasis and their mechanisms. Methods: We integrated bulk RNA sequencing datasets from the GEO database to construct and evaluate exosome-related patterns. Subsequently, exosome-related ncRNAs in psoriasis lesions were identified primarily through weighted gene co-expression network analysis and five machine learning algorithms. Additionally, large-scale integrated single-cell RNA sequencing data and genome-wide association study (GWAS) data were included to investigate the mechanisms of key ncRNA, primarily through immune infiltration analysis, gene set enrichment analysis (GSEA), co-expression analysis, and Mendelian randomization. Finally, the mechanisms of key ncRNA were confirmed primarily through cell co-culture and lentiviral transfection, assessed by immunofluorescence, qRT-PCR, and Western blot. Results: We identified 10 exosome-related ncRNAs, including PRKCQ-AS1, and constructed five machine learning models with excellent diagnostic performance, emphasizing PRKCQ-AS1’s significance. Mendelian randomization demonstrated a causal relationship between PRKCQ-AS1 and psoriasis. Immune infiltration analysis and GSEA indicated that PRKCQ-AS1 influences the infiltration pattern of CD4+T cells, promotes Th17 differentiation, and is related to STAT3. The expression distribution in single-cell RNA sequencing data suggested that exosomal PRKCQ-AS1 may originate from keratinocytes, and co-expression analysis supported its role in STAT3 activation within lymphocytes. Co-culture experiments confirmed that keratinocytes in psoriasis models, as well as keratinocytes overexpressing PRKCQ-AS1, can upregulate PRKCQ-AS1 levels in CD4+T cells via exosomes, promoting Th17 cell differentiation and IL-17 secretion. Consistent results and STAT3 signaling pathway activation were detected in CD4+T cells overexpressing PRKCQ-AS1. Conclusion: PRKCQ-AS1 is an exosomal lncRNA from keratinocytes in psoriasis, promoting Th17 differentiation and IL-17 secretion through STAT3 activation. This finding deepens the understanding of psoriasis pathogenesis and provides a basis for targeted therapies.

1 January 2026 in Dermatologic Therapy
Verified
Journal Article
Open access
XGXiaolu Gao
Xiaolu Gao
PGPengfei Gao
Pengfei Gao
MZMing Zhang
Ming Zhang
LLLong Lin
Long Lin
CCChuyan Chen
Chuyan Chen
RYRuisi Yang
Ruisi Yang
Background: Association between niacin and multiple psoriasis‐related mechanisms suggests that it may play a potential role in the disease’s onset and progression. However, the “niacin paradox” described in the cardiovascular field, along with other studies on adverse outcomes associated with niacin, highlights its complex role. The association between dietary niacin intake (DNI) and psoriasis risk remains unclear, and this study aimed to evaluate this association. Methods: Data from the NHANES were utilized. Psoriasis diagnosis was determined via questionnaire, and DNI was calculated from two 24‐h dietary recall. Generalized additive model (GAM) and restricted cubic spline (RCS) analyses, followed by categorized and segmented logistic regression, were applied to assess the associations. Subgroup analyses and bootstrap resampling to assess the stability of the peak location were conducted to evaluate the reliability and robustness of the findings. Results: Among 17,653 participants, both the GAM and the RCS showed a nonmonotonic association between DNI and psoriasis risk ( p < 0.05 for all three models under both methods). Risk was lower in the lowest quartile (OR = 0.70, 95% CI: 0.53–0.93, p = 0.013) and in the highest quartile (OR = 0.73, 95% CI: 0.56–0.96, p = 0.024) than in the two middle quartiles combined, and the difference in slope between the two segments about the median was significant (OR per 10 mg/day = 0.61, 95% CI: 0.41–0.91, p = 0.016). Findings observed in the crude model were consistent in the adjusted models and across subgroups, with no significant interaction between DNI and any of the stratification variables (all p > 0.05). Conclusions: The nonmonotonic association between DNI and psoriasis risk—namely, that “more is not always better”—suggests directions for future research and underscores the importance of refined DNI assessment in psoriasis management and other relevant applications.